News Summary

NeuroBionics, an MIT spinout, is pioneering a minimally invasive approach to treating neurological conditions such as depression, epilepsy, and Parkinson’s disease. The startup, founded by MJ Antonini and Nicky Driscoll, has developed bioelectric fibers as thin as human hair that can be guided through blood vessels in the brain, offering an alternative to traditional deep brain stimulation, which requires major open brain surgery. These fibers, powered by a standard implantable battery, use carbon nanotubes instead of metals, reducing toxicity and enhancing durability. NeuroBionics recently secured $5 million in funding led by Dolby Family Ventures to advance its clinical device. The company’s technology is set to undergo safety and efficacy tests in pigs, with potential human trials by 2030. The innovation promises to open the market for deep brain stimulation, currently limited to a few advanced hospitals.